Ferrum

Quick links to important sections

Ferrum

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ferrum

What is Ferrum? Defining a Combination Hematinic Agent

Property Description
Active ingredient Iron (Ferrum) and Folic Acid (Vitamin B9)
Form Oral tablets, capsules, or solution
Pharmacological class Antianemic Agent (Hematinic), Micronutrient Supplement
General purpose Supports red blood cell formation and oxygen transport
Origin Essential trace element (Iron) and synthetic B-vitamin (Folic Acid)

1. What Type of Medicine is the Ferrum and Folic Acid Combination?

This medicinal product is classified as a combination antianemic agent, or hematinic, designed to supply essential nutrients for blood cell formation. It is a targeted micronutrient supplement that combines the trace element Iron (Ferrum) with Folic Acid (Vitamin B9) in a single preparation. Iron and folic acid preparations are regarded as essential medicines for their role in deficiency management. This designation underscores the medicine's role in meeting public health needs. This specific combination is widely utilized by health authorities globally, a practice supported by clinical consensus. This product is typically manufactured in oral dosage forms, such as tablets, capsules, or oral solution, facilitating convenient administration.


2. The Composition and Origin of the Hematinic Agent

The preparation contains two primary active ingredients: an Iron compound, usually a highly absorbable ferrous salt, and Folic Acid, which is a synthetically produced form of the essential B-vitamin folate. While Iron is a naturally occurring essential trace element pivotal for oxygen transport, the Folic Acid component is a crucial nutrient supporting cellular processes, including DNA synthesis. Both iron and folic acid are necessary for the formation and maturation of red blood cells. The preparation is specifically formulated for patients requiring simultaneous replenishment of both components. This dual-component focus differentiates it from single-ingredient supplements, making it a distinct therapeutic choice clinically recognized for targeted deficiency support.


3. General Purpose: What Does Ferrum with Folic Acid Help Achieve?

The general purpose of this antianemic agent is to supply the necessary building blocks for the body to sustain proper and efficient red blood cell formation (erythropoiesis). By providing the essential mineral Iron for hemoglobin synthesis and Folic Acid for the creation of new red cells, the medicine supports the maintenance of adequate oxygen transport capacity throughout the body. A typical, neutral use scenario involves prophylactic administration to certain patient groups, such as those with increased physiological demands. The utility of this combination is strictly focused on helping the body restore its ability to generate sufficient healthy blood components, ensuring fundamental physiological functions are supported.

Regulatory References

  1. essential medicines
  2. WHO Model List of Essential Medicines
  3. Iron Supplements: MedlinePlus Drug Information

What side effects are possible with Ferrum?

Possible Side Effects and Safety Information

The safety profile for iron replacement therapy, or Ferrum, is highly dependent on the route of administration (oral versus intravenous) and requires distinct regulatory warnings.

Oral Iron Side Effects

The most frequently reported adverse reactions for oral iron preparations (such as ferrous salts) are categorized under the Gastrointestinal System. These reactions are common and include:

  • Constipation
  • Diarrhea
  • Nausea and vomiting
  • Abdominal pain or cramps
  • Black or dark-colored stools (a common and expected effect)

Accidental overdose of iron-containing products is cited in regulatory documents as a leading cause of fatal poisoning in children under the age of 6.

Intravenous (IV) Iron Safety

Intravenous iron administration carries a specific risk of serious, potentially fatal hypersensitivity reactions, including anaphylaxis. Regulatory authorities, such as the FDA, have mandated Boxed Warnings for certain IV iron formulations due to this risk.

Serious Adverse Reactions

  • Life-threatening anaphylactic-type reactions (e.g., hypotension, syncope, cardiac arrest).
  • Hypotension (low blood pressure).

To manage this risk, IV iron is administered only when personnel and therapies are immediately available for the treatment of anaphylaxis. Patients must be closely monitored for at least 30 minutes following each infusion, as most severe reactions begin during or shortly after administration.

Contraindications and Restrictions

Iron preparations are typically contraindicated in patients with a known history of allergic reaction to the specific product or in those with evidence of iron overload (e.g., haemochromatosis).

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for a Ferrum (Iron and Folic Acid) overdose is fundamentally defined by the acute toxicity of the Iron component. Overdose typically commences with rapid-onset gastrointestinal manifestations, which may include vomiting, diarrhea, abdominal pain, and potentially bloody stools (melena). These initial signs are critical as the toxicity can progress rapidly, sometimes after a period of apparent stabilization.

High-dose iron toxicity can rapidly progress to life-threatening conditions. Severe outcomes documented in regulatory labeling include hypotension (shock), profound metabolic acidosis, acute liver failure (hepatotoxicity), and severe neurological symptoms such as seizures and coma. Regulatory guidance emphasizes that accidental overdose remains a leading cause of fatal poisoning in children under six years of age.

Due to the severity of these effects, the official mandate is to seek immediate medical attention or call a poison control center immediately if overdose is suspected. Management documented in official labeling requires hospital monitoring and supportive care to stabilize systemic functions. For confirmed severe poisoning, the specific chelating agent Deferoxamine is required to bind and remove excess iron from the body.

Therapeutic Uses of Ferrum

What Ferrum Treats: Main Uses and Benefits


The primary therapeutic role of this medication is to address and prevent nutritional deficiency anemias arising from an inadequate supply of both iron (Ferrum) and folic acid. This combination is a recognized application used to improve essential blood components and support the management of situations associated with deficiency.

This medicinal combination is commonly used to help with conditions involving systemic imbalance where established mixed nutritional anemia or iron deficiency anemia is verified. It is relevant for managing established anemias, addressing latent iron deficiency, and supporting the body during high-demand states. The treatment plays a role in managing severe symptoms related to physical discomfort, such as extreme fatigue, persistent weakness, and associated shortness of breath.

Quick Facts

Quick Fact: Symptomatic Relief and Prophylaxis
Symptom Focus: Helps address symptom clusters that may become intense or disruptive, particularly fatigue and physical weakness that interfere with daily functioning.
Clinical Scenario: This combination is applicable in clinical settings that involve acute or unstable symptom patterns, such as during pregnancy or following chronic blood loss.
Patient Benefit: Provides support that helps ease the overall symptom burden and assists with maintaining functional stability during symptomatic phases.

Regulatory References

  1. World Health Organization's guidance on Antenatal Iron Supplementation

Eligibility and Restrictions for Use

Who Can and Cannot Use Ferrum?

This section outlines the official population eligibility and exclusion criteria for medicinal iron compounds (Ferrum), based strictly on government regulatory documents.


Contraindicated Populations (Must Not Use)

Classification Exclusion Criterion
Iron Overload Patients with syndromes of iron overload, such as hemochromatosis or hemosiderosis.
Anemia Type Patients with anemias not caused by iron deficiency (e.g., hemolytic anemia).
Allergy/Reaction History of known hypersensitivity to the specific iron compound or any excipients.

Restricted or Conditional Use

Population/Condition Restriction
IV Iron Use Eligibility is often restricted to patients who cannot tolerate or have had an unsatisfactory response to oral iron.
Pregnancy Intravenous iron is generally not recommended in the first trimester; if necessary, administration is confined to the second or third trimester.
Pediatric Products must be kept out of reach of children under 6 due to the risk of fatal accidental poisoning. Safety and efficacy are not established for some products in younger pediatric groups.
GI Disease Oral forms may be unsuitable or cautioned in patients with active peptic ulcer or inflammatory bowel disease (IBD).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information regarding Ferrum (iron salts/supplements) primarily documents interactions based on chelation, binding, and changes in gastric acidity that alter drug absorption. These interactions necessitate specific administration constraints to maintain the efficacy of iron and co-administered medicines.


Contraindicated and High-Risk Combinations

  • Deferiprone: Co-administration with iron supplements is generally contraindicated due to the risk of additive toxicity. Specific warnings exist against combining oral iron with intravenous iron.
  • Dimercaprol: Concomitant use is documented as nephrotoxic.

Reciprocal Exposure Modification

Ferrum significantly reduces the systemic absorption (bioavailability) of several drug classes due to binding in the gastrointestinal tract. Conversely, some substances reduce iron absorption.

Substance Whose Absorption is Decreased by Iron Substance That Decreases Iron Absorption
Tetracycline and Quinolone Antibiotics Antacids (Aluminum/Magnesium)
Levothyroxine, Levodopa, Penicillamine Calcium/Magnesium Supplements
Bisphosphonates, Mycophenolate, Eltrombopag Proton Pump Inhibitors/H2-Blockers

Timing and Context Constraints

The regulatory profile mandates temporal separation to mitigate most binding interactions. Iron should be spaced at least 2 to 4 hours apart from agents such as antacids, tetracyclines, bisphosphonates, and levothyroxine. Furthermore, food, milk, tea, and coffee are documented to reduce iron absorption, restricting the oral administration context.

Mechanism of Action

Mechanism of Action

Ferrum, or iron, functions mechanistically as a critical component in the heme structure of hemoglobin and myoglobin. Following absorption, iron is transported via the plasma protein transferrin and primarily deposited into erythroid progenitor cells within the bone marrow. The iron then binds to the protoporphyrin ring, forming the functional heme unit.

This heme unit is essential for the molecular binding and transport of oxygen ( O2) from the pulmonary capillaries to peripheral tissues. Beyond oxygen transport, iron is a required cofactor for numerous enzymatic reactions. Specifically, it is incorporated into the active site of various cytochromes and non-heme enzymes, including those critical to electron transport chain (ETC) function within the mitochondria. Iron-containing proteins facilitate cellular energy production and are required for the synthesis and metabolism of DNA and certain neurotransmitters. The maintenance of adequate iron stores is regulated by the peptide hormone hepcidin, which controls the release of iron from enterocytes and macrophages via modulation of the ferroportin transporter.

Dosage and Administration Information

How to Use Ferrum and Folic Acid

This section outlines the general administration guidelines for the oral combination of Iron (Ferrum) and Folic Acid.


Administration Scope

Parameter Administration Guidelines
Route of administration Oral (PO)
Dosing schedule For treatment, the typical adult regimen delivers 100 mg to 200 mg of Elemental Iron daily, usually taken as one unit two to three times daily. For prophylaxis, a common dose is one unit (65 mg elemental iron) once daily.
Timing in relation to meals Best absorbed when taken on an empty stomach (one to two hours away from meals). May be taken with food if stomach sensitivity is a concern.
Age-group administration rules Pregnant Females: Specific dose of 30 mg to 60 mg of Elemental Iron combined with 400 μg to 800 μg of Folic Acid is often used for daily prophylaxis.
Special handling Extended-release or delayed-release forms must be swallowed whole and must not be crushed or chewed.

Official Use Protocol

Frequency Pattern: Daily dosing is the standard approach, although the regimen can be divided (multiple times daily) for treatment or administered weekly for certain prophylactic protocols.

Duration of Use: For treating established deficiency, use typically continues for three to six months after the deficiency is corrected to ensure body stores are fully replenished.

Connection to the overall use protocol: The administration protocol establishes the oral route as mandatory and defines the specific daily dose range required for both treatment and prevention. The instructions further govern the use by imposing restrictions on tablet handling and specifying optimal timing relative to meals to ensure the medicine is properly absorbed and administered.

Recent Clinical Evidence

Research evidence / Overview of studies for Ferrum


Evidence for use in Iron Deficiency Anemia (IDA)

This section will summarize the research studies and clinical trials that have investigated the use of Ferrum for managing Iron Deficiency Anemia (IDA), outlining the types of evidence available from studies that have explored iron status.

For Iron Deficiency Anemia (IDA)—a condition characterized by outcomes related to systemic or functional imbalance—research has primarily focused on clinical trials. These studies have evaluated the use of Ferrum in adults with documented iron deficiency. The research examined whether the use of Ferrum was associated with changes in blood measurements related to iron levels over defined time intervals.


Evidence for use in Restless Legs Syndrome (RLS)

This part of the section will review the available evidence from studies and trials exploring the use of Ferrum in individuals with Restless Legs Syndrome (RLS) and describe what research has explored in this area.

Restless Legs Syndrome (RLS) is a condition often characterized by fluctuating or episodic manifestations and outcomes related to physical discomfort. Research into Ferrum for RLS has explored its use in studies applied in research contexts involving fluctuating or unstable symptoms. The primary focus research examined whether it was associated with changes in outcomes related to physical discomfort.


Long-term studies and follow-up

Research into the long-term effects of Ferrum has monitored outcomes over extended time periods after initial use. This type of research was evaluated in settings that look at the durability of patterns observed in iron status in conditions marked by functional limitations.

Follow-up durations were limited in many of the core clinical studies. Consequently, long-term effects are not fully established, and there is limited information for long-term outcomes.


Evidence in special populations

Studies have evaluated Ferrum in certain groups outside of the general adult population. For example, some research has been studied for its use in children with IDA, a population presenting with cycles of stability and flare-ups related to growth. The research also examined pregnant-related populations, was evaluated in settings focusing on outcomes monitoring physiological strain or stress.

However, data for certain groups remain insufficient. For instance, evidence in older adults or those with complex comorbid conditions is often more limited.


What is still uncertain about Ferrum

What is still uncertain remains a focus in the research landscape for Ferrum. Comparative evidence is lacking to definitively show if one formulation or approach is superior to another for all people and all conditions. Furthermore, the findings related to specific non-IDA conditions, such as RLS, were mixed across different studies, meaning certainty remains low.

Another major gap is that long-term effects are not fully established, as follow-up durations were limited in many of the key studies. Findings describe group patterns, not personal outcomes. The research does not determine whether an individual will respond similarly to the group patterns observed.

Frequently Asked Questions (FAQ)

Common questions about Ferrum (FAQ)


Q: Does Ferrum affect energy levels or fatigue?

A: Official information describes Ferrum (iron) as a fundamental component of hemoglobin, which is essential for the transport of oxygen throughout the body. The general purpose of the medicine is to supply essential nutrients for proper red blood cell formation, which supports fundamental physiological functions required for cellular energy production and oxygen transport.


Q: Can Ferrum cause changes in stool color or bathroom habits?

A: Yes, official safety information for oral iron preparations frequently reports changes in the gastrointestinal system. These reactions include constipation or diarrhea. Additionally, the appearance of black or dark-colored stools is a common and expected effect of taking oral iron.


Q: Is it normal to feel nauseous after taking Ferrum?

A: Regulatory safety documents list nausea and vomiting among the most frequently reported adverse reactions for oral iron preparations. Because it is a common reported reaction, official administration instructions state that the medicine may be taken with food if stomach sensitivity is a concern.


Q: Is Ferrum safe to take if I am already taking vitamins?

A: Official information notes that certain supplements, such as calcium or magnesium, can decrease iron absorption due to binding in the stomach. While Ferrum already contains Folic Acid (a B-vitamin), official warnings exist about taking other supplements that contain iron simultaneously. Temporal separation or avoidance of certain co-administered supplements is commonly discussed in the context of optimizing iron absorption.


Q: Does the body develop a tolerance to Ferrum over time?

A: The body regulates the amount of iron it absorbs using a hormone called hepcidin, which controls iron release into the bloodstream. The duration of use is generally described as continuing until the deficiency is corrected and body stores are replenished, which is the primary focus of the therapy.


Q: Can Ferrum be used during pregnancy or while breastfeeding?

A: The use of oral Ferrum and Folic Acid in pregnancy is supported by specific protocols and dose ranges for prophylaxis (prevention). Regarding breastfeeding, official data indicate that the amount of iron transferred into breast milk is not expected to cause adverse effects in a breastfed infant.


Q: Can Ferrum affect kidney function?

A: Official regulatory documents do not list a general warning for Ferrum alone affecting kidney function. However, regulatory documents document that the concomitant use of iron with the medicine Dimercaprol has been described as nephrotoxic (toxic to the kidneys).


Q: Can Ferrum be crushed or split if a person has trouble swallowing pills?

A: Regulatory documents explicitly state that certain preparations, specifically extended-release or delayed-release forms, must be swallowed whole. These types of tablets must not be crushed, chewed, or split, as this may affect the release mechanism of the medicine.


Q: Why do some people call Ferrum a 'blood medicine'?

A: Official sources classify Ferrum and Folic Acid as an antianemic agent or hematinic. This is a category of medicine that supplies essential building blocks required for the body to sustain proper red blood cell formation and oxygen transport. This core function is central to blood health and oxygen transport, which is why it is commonly referred to in this way.


Q: How quickly can I expect to notice any effects from Ferrum?

A: Scientific literature notes that the process of forming new red blood cells takes approximately three to four weeks. Based on this physiological timeline, iron utilization is described as peaking after approximately two to three weeks.


Q: Is Ferrum meant for short-term or long-term use?

A: The duration of use is typically determined by clinical goals. For treating an established deficiency, official guidance describes use continuing for three to six months after the deficiency is corrected to ensure the body’s iron stores are fully replenished.


Q: What are the most common things people feel when they start taking Ferrum?

A: The most frequently reported physical feelings for oral iron preparations are related to the gastrointestinal system. These are common adverse reactions listed in official documents, including constipation, diarrhea, nausea, and abdominal pain.


Q: Are there any specific foods or drinks that should be avoided while taking Ferrum?

A: Yes, regulatory profiles mandate avoiding certain substances around the time of administration. This includes food, milk, tea, and coffee as they are documented to reduce iron absorption. Official administration documents mandate that these items be separated from the dose by at least one to two hours.


Q: Is there a certain time of day that is considered 'best' for taking Ferrum?

A: Official instructions state that taking the medicine on an empty stomach is recommended to promote iron absorption. Scientific literature suggests that iron absorption may be physiologically diminished on the second day due to the body’s regulatory hormones, which is part of the rationale for considering the timing of a once-daily dose.


Q: Do studies support the use of Ferrum for conditions other than its main approved uses?

A: Research has examined the use of Ferrum in conditions other than Iron Deficiency Anemia (IDA), such as Restless Legs Syndrome (RLS). However, official research summaries note that the findings related to these non-IDA conditions were often inconsistent across different studies.


Q: What kind of research has been done on the long-term effects of Ferrum?

A: Research has monitored outcomes over extended time periods to study the durability of observed patterns in iron status. However, official summaries note that the follow-up durations were limited in many core clinical studies, meaning long-term effects are not fully established.


Q: If I have a sensitive stomach, is Ferrum still an option?

A: If stomach sensitivity is a concern, official administration instructions state that the medicine may be taken with food, noting that this context may lead to reduced absorption. In cases of severe gastrointestinal disease (like active peptic ulcer), oral forms may be unsuitable or cautioned according to regulatory standards.


Q: What is the difference between Ferrum and other medicines that treat similar symptoms?

A: Ferrum is officially classified as a micronutrient supplement and an antianemic agent. Its unique role is to supply the essential building blocks, Iron and Folic Acid, that the body requires to sustain proper red blood cell formation and oxygen transport capacity.


Q: Are there different forms or strengths of Ferrum?

A: Official documents describe Ferrum as being available in various oral dosage forms, such as tablets, capsules, or solutions. Official documents describe these forms as providing a specific amount of the active component known as Elemental Iron.


Q: How long after stopping Ferrum does it stay in the body?

A: Iron is a naturally occurring element that is tightly regulated by the body. Once absorbed, the body has no active process for excretion; instead, the iron is stored, primarily as ferritin, or utilized for essential functions. The body's control is primarily focused on regulating absorption.


Q: Why is Ferrum sometimes described with a specific chemical name?

A: Ferrum (iron) is provided in medicinal products as various iron compounds or salts, such as ferrous sulfate or ferrous fumarate. Official labels use the specific chemical name to accurately describe the ingredient used to deliver the active component known as Elemental Iron.


Q: Do food restrictions apply only when taking the medicine, or all day?

A: The regulatory profile mandates a temporal separation from certain foods, milk, tea, and coffee to mitigate binding and reduced absorption. The restrictions apply only to the hours immediately surrounding the dose, typically requiring separation by at least one to two hours.


Q: Are there genetic factors that influence how a person responds to Ferrum?

A: Yes, iron preparations are typically contraindicated in individuals with syndromes of iron overload, such as hemochromatosis. This condition often has a genetic basis that results in the body absorbing and storing too much iron.


Q: Why would a doctor recommend taking Ferrum every other day?

A: Studies have examined intermittent dosing schedules, such as every other day, to potentially support iron absorption. This research explores bypassing a physiological reduction in iron bioavailability that may occur on consecutive days of high-dose supplementation.


Q: Is Ferrum suitable for people who are vegetarian or vegan?

A: The active ingredients are the essential trace element iron and the synthetic B-vitamin Folic Acid. Regulatory-supported literature notes that individuals on vegetarian diets often have a higher prevalence of depleted iron stores.


Q: Can Ferrum make certain pre-existing conditions worse?

A: Official documents describe certain populations where iron preparations are unsuitable or cautioned. This includes patients with pre-existing conditions such as active peptic ulcer or inflammatory bowel disease (IBD). Iron is also contraindicated in anemias not caused by iron deficiency.


Q: Does the effectiveness of Ferrum depend on the person's age?

A: Research has evaluated Ferrum in special populations, including studies in children and pregnant-related populations. However, official research summaries note that available data for certain groups, such as older adults, is often more limited compared to children and pregnant-related populations.


Q: What is the average duration of treatment with Ferrum described in research?

A: For treating established deficiency, the duration of use is generally described in official guidance as continuing for three to six months after the deficiency is corrected. This time frame is intended to ensure body stores are fully replenished.


Q: Is there a risk of accidental overdose with Ferrum?

A: Regulatory documents cite the accidental overdose of iron-containing products as a leading cause of fatal poisoning in children under the age of six. Regulatory documents explicitly contain a warning that all iron-containing products should be stored out of the reach and sight of children to mitigate this risk.


Q: What do patient information leaflets say about taking Ferrum with coffee or tea?

A: Patient information emphasizes the need to avoid coffee or tea within at least one hour before or two hours after taking the iron product. This is due to the documented effect these beverages have in reducing the absorption of iron.

How should Ferrum be stored and disposed of?

How to Store and Dispose of Ferrum

Official labeling defines strict conditions for storing iron (ferrum) preparations to maintain their stability.

Storage Requirements

The medicine must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Regulatory documents specify that the product must not be refrigerated or frozen. The product should be kept in its original container, which must remain tightly closed to protect the contents from light and moisture.

For child safety, all iron-containing products must be stored out of the reach and sight of children at all times.

Disposal Instructions

Unused or expired iron medicine must be disposed of according to local regulations. Regulatory instructions state that the product must not be discarded into wastewater or regular household trash, except when following specific regulatory guidance (e.g., FDA-approved household disposal methods).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ferrum found in:

A-Z Index: